China SXT Pharmaceuticals, Inc.

PROXY STATEMENT

The board of directors (the “Board”) of China SXT Pharmaceuticals, Inc. (the “Company”) is soliciting proxies for the special meeting of shareholders (the “Meeting”) of the Company to be held on July 28, 2025, at 9 a.m. EST time, at 178 Taidong Road North Taizhou, Jiangsu, People’s Republic of China and any adjournment thereof.

Only holders of the ordinary shares of the Company (the “Ordinary Shares”) of record at the close of business on July 9, 2025 (the “Record Date”) are entitled to attend and vote at the Meeting or at any adjournment thereof. The shareholders entitled to vote in person or by proxy or (in the case of a shareholder being a corporate entity) by its duly authorized representative representing not less than one-third of all votes attaching to the total issued voting shares in the Company throughout the Meeting shall form a quorum. When counting the quorum, each issued and outstanding Ordinary Share in the Company has one vote.

Any shareholder entitled to attend and vote at the Meeting is entitled to appoint a proxy to attend and vote on such shareholder’s behalf. A proxy need not be a shareholder of the Company. Each holder of the Company’s Ordinary Shares shall be entitled to one vote in respect of each Ordinary Share held by such holder on the Record Date.